Investigation of Relaxin-3 Serum Levels in terms of Social Interaction, Communication, and Appetite as a Biomarker in Children with Autism

키워드

참고문헌 (47)

1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Association
2. Xu G, "Prevalence and treatment patterns of autism spectrum disorder in the United States, 2016", JAMA Pediatr, 173, pp.153~159 (2019)
3. Frye RE, "Emerging biomarkers in autism spectrum disorder : a systematic review", Ann Transl Med, 7, pp.792~ (2019)
4. Smith CM, "Relaxin-3", RXFP3 networks : an emerging target for the treatment of depression and other neuropsychiatric diseases?, 2014, pp.5, 46~
5. Burazin TC, "Restricted, but abundant, expression of the novel rat gene-3(R3)relaxin in the dorsal tegmental region of brain", J Neurochem, 82, pp.1553~1557 (2002)
6. Ma S, "Dual-transmitter systems regulating arousal, attention, learning and memory", Neurosci Biobehav Rev, 85, pp.21~33 (2018)
7. Smith CM, "Relaxin-3systems in the brain--the first 10 years", J Chem Neuroanat, 42, pp.262~275 (2011)
8. Banerjee A, "Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation", Neuropharmacology, 58, pp.145~155 (2010)
9. Ganella DE, "Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides : functional and therapeutic implications", Behav Pharmacol, 23, pp.516~525 (2012)
10. Richards R, "Increased hippocampal shape asymmetry and volumetric ventricular asymmetry in autism spectrum disorder", Neuroimage Clin, 26, pp.102207~ (2020)
11. Fan J, "Functional deficits of the attentional networks in autism", Brain Behav, 2, pp.647~660 (2012)
12. Lukas M, "The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice", Neuropsychopharmacology, 36, pp.2159~2168 (2011)
13. McNamara IM, "Further studies in the developmental hyperserotonemia model(DHS)of autism : social, behavioral and peptide changes", Brain Res, 1189, pp.203~214 (2008)
14. Rytova V, "Chronic activation of the relaxin-3 receptor on GABA neurons in rat ventral hippocampus promotes anxiety and social avoidance", Hippocampus, 29, pp.905~920 (2019)
15. Albert-Gasco H, "Central relaxin-3 receptor(RXFP3)activation impairs social recognition and modulates ERK-phosphorylation in specific GABAergic amygdala neurons", Brain Struct Funct, 224, pp.453~469 (2019)
16. Smith CM, "Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain", J Comp Neurol, 518, pp.4016~4045 (2010)
17. Kuei C, "R3(BDelta23 27)R", I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7 : in vitro and in vivo characterization, 2007, pp.282, 25425~25435
18. Hida T, "Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats", J Recept Signal Transduct Res, 26, pp.147~158 (2006)
19. Sabatier N, "Oxytocin, feeding, and satiety", Front Endocrinol(Lausanne), 4, pp.35~ (2013)
20. Klockars A, "Central oxytocin and food intake: focus on macronutrient-driven reward", Front Endocrinol(Lausanne), 6, pp.65~ (2015)
21. Kublaoui BM, "Oxytocin deficiency mediates hyperphagic obesity of Sim1haploinsufficient mice", Mol Endocrinol, 22, pp.1723~1734 (2008)
22. Kaufman J, "K-SADS-PL", J Am Acad Child Adolesc Psychiatry, 39, pp.1208~ (2000)
23. Schedule for affective disorders and schizophrenia for school-aged children: present and lifetime version (K-SADS-PL) DSM-5- November 2016 working draft, "Kaufman J", Yale University, ~ (2016)
24. Ünal F, "Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)", Turk Psikiyatri Derg, 30, pp.42~50 (2019)
25. Schopler E, "Toward objective classification of childhood autism : Childhood Autism Rating Scale(CARS)", J Autism Dev Disord, 10, pp.91~103 (1980)
26. Sucuoğlu B, "A study about childhood autism scales", J Psychiatry Psychol Psychopharmacol, 4, pp.117~121 (1996)
27. Hergüner S, "Turkish child and adolescent psychiatry association publications", pp.37~40 (2010), Nobel Yayıncılık
28. Aman MG, "The aberrant behavior checklist : a behavior rating scale for the assessment of treatment effects", Am J Ment Defic, 89, pp.485~491 (1985)
29. Karabekiroglu K, "Validity of the aberrant behavior checklist in a clinical sample of toddlers", Child Psychiatry Hum Dev, 40, pp.99~110 (2009)
30. Wardle J, "Development of the Children’s Eating Behaviour Questionnaire", J Child Psychol Psychiatry, 42, pp.963~970 (2001)
31. Yilmaz R, "Çocuklarda yeme davranışıanketinin Türkçe uyarlama çalışması", Anadolu Psikiyatri Derg, 12, pp.287~294 (2011)
32. Ma S, "Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat", J Physiol, 591, pp.3981~4001 (2013)
33. Manji HK, "Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression", Biol Psychiatry, 53, pp.707~742 (2003)
34. Marson L, "Identification of neural pathways involved in genital reflexes in the female : a combined anterograde and retrograde tracing study", Neuroscience, 127, pp.723~736 (2004)
35. Espejo EF, "Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt’s test", Neuroscience, 88, pp.609~615 (1999)
36. Anand A, "Activity and connectivity of brain mood regulating circuit in depression : a functional magn etic resonance study", Biol Psychiatry, 57, pp.1079~1088 (2005)
37. Yoshida M, "Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice", J Neurosci, 29, pp.2259~2271 (2009)
38. Nakazawa CM, "Prediction of relaxin-3-induced downstream pathway resulting in anxiolytic-like behaviors in rats based on a microarray and peptidome analysis", J Recept Signal Transduct Res, 33, pp.224~233 (2013)
39. de Ávila C, "Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats", Psychopharmacology(Berl), 237, pp.1091~1106 (2020)
40. Ma S, "Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat", Neuroscience, 144, pp.165~190 (2007)
41. Binder EB, "The CRF system, stress, depression and anxiety-insights from human genetic studies", Mol Psychiatry, 15, pp.574~588 (2010)
42. Smith CM, "Behavioral phenotyping of mixed background(129S5 : B6)relaxin-3knockout mice", Ann N Y Acad Sci, 1160, pp.236~241 (2009)
43. Watanabe Y, "Relaxin-3-deficient mice showed slight alteration in anxiety-related behavior", Front Behav Neurosci, 5, pp.50~ (2011)
44. Ryan PJ, "Central relaxin-3 receptor(RXFP3)activation decreases anxiety-and depressive-like behaviours in the rat", Behav Brain Res, 244, pp.142~151 (2013)
45. McGowan BM, "Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats", Regul Pept, 136, pp.72~77 (2006)
46. Haugaard-Kedström LM, "Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3receptor RXFP3", J Am Chem Soc, 133, pp.4965~4974 (2011)
47. Ganella DE, "Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus", Gene Ther, 20, pp.703~716 (2013)

관련 논문AI추천